CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS
Hemasphere
.
2022 Jun 17;6(7):e733.
doi: 10.1097/HS9.0000000000000733.
eCollection 2022 Jul.
Authors
Wiebke Rösler
1
,
Andrea Bink
2
,
Marina Bissig
1
,
Lukas Imbach
3
,
Ewerton Marques Maggio
4
,
Markus G Manz
1
,
Thomas Müller
5
,
Patrick Roth
3
,
Elisabeth Rushing
6
,
Corinne Widmer
1
,
Thorsten Zenz
1
,
Seraina von Moos
5
,
Antonia M S Müller
1
7
Affiliations
1
Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.
2
Department of Neuroradiology, University Hospital Zurich, Switzerland.
3
Department of Neurology, University Hospital Zurich, Switzerland.
4
Institute of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland.
5
Department of Nephrology, University Hospital Zurich, Switzerland.
6
Institute of Neuropathology, University Hospital Zurich, Switzerland.
7
Department of Blood Group Serology and Transfusion Medicine, University Hospital Vienna, Austria.
PMID:
35747591
PMCID:
PMC9208876
DOI:
10.1097/HS9.0000000000000733
No abstract available
Publication types
Case Reports